Related Experiment Video
Updated: Apr 21, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Bacteremia caused by Eggerthella lenta in an elderly man with a gastrointestinal malignancy: A case report
Davie Wong1, Fred Aoki2, Ethan Rubinstein2
1Internal Medicine, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba.
Abstract:
Eggerthella lenta is an anaerobic, Gram-positive bacillus commonly found in the human digestive tract. Occasionally, it can cause life-threatening infections. Bacteremia due to this organism is always clinically significant and is associated with gastrointestinal diseases and states of immune suppression. The authors report a case involving an elderly man with a newly diagnosed gastrointestinal malignancy who developed bacteremia caused by E lenta, treated successfully using empirical therapy with vancomycin and piperacillin-tazobactam, followed by directed therapy with metronidazole once the identity and antibiotic susceptibility of the organism was established. The present case reinforces the connection between E lenta bacteremia with gastrointestinal malignancy and highlights the importance of searching for a source of bacteremia due to this organism.
Insights
Eggerthella lenta bacteremia is a serious infection linked to gastrointestinal issues and immune suppression. Successful treatment involved empirical and targeted antibiotics, emphasizing source identification.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Eggerthella lenta is an anaerobic, Gram-positive bacillus residing in the human gut.
- While typically commensal, E. lenta can precipitate severe, life-threatening infections.
- Bacteremia caused by E. lenta is clinically significant, often correlating with gastrointestinal pathologies and immunosuppression.
Observation:
- A case study involving an elderly male patient with newly diagnosed gastrointestinal malignancy.
- The patient developed bacteremia attributed to E. lenta.
- Initial empirical treatment comprised vancomycin and piperacillin-tazobactam.
Findings:
- The patient's E. lenta bacteremia was successfully treated.
- Directed therapy with metronidazole was administered post-identification and susceptibility testing.
- The case underscores the association between E. lenta bacteremia and gastrointestinal malignancy.
Implications:
- Highlights the critical importance of investigating the source of E. lenta bacteremia.
- Reinforces the link between E. lenta bacteremia and underlying gastrointestinal malignancy.
- Informs clinical management strategies for E. lenta infections, particularly in immunocompromised patients or those with GI disease.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Gastroenteritis
Development of Human Microbiota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Microbiota of the Urogenital Tract
